Repositive and AstraZeneca Announce Initial Members of PDX Consortium

Members Include Boehringer Ingelheim, Merck Group and Horizon Discovery Cambridge, 7 December 2016 ... Repositive, a software company developing novel tools to improve discovery and access to human genomic research data, and AstraZeneca have announced the inaugural members of the PDX Consortium, which was set up ...

Repositive Now Largest Portal for Human Genomic Data

Cambridge, 13 October 2016 ... The number of datasets discoverable through the Repositive platform has now reached over one million, making Repositive the world’s largest portal for accessing human genomic data. Repositive, a software company developing novel tools to improve access to human genomic research ...

Find the right PDX model for your research

There is a desperate need to improve the success of drug development in the field of oncology. The rate at which preclinical agents fail to demonstrate sufficient safety or efficiency in oncology clinical trials has been pegged between 85% to 95% . Furthermore, assuming a drug ...

Repositive Launches Consortium with AstraZeneca to Improve Oncology Research

Cambridge, UK, Thursday 4th August 2016 … Repositive, a software company developing novel tools to improve access to human genomic research data, is launching a consortium project in collaboration with AstraZeneca to develop a collaborative, pre-competitive resource, to provide streamlined discovery and access to molecular data ...